BRCA2

BRCA2
Dostupne strukture
PDBPretraga ortologa: PDBe RCSB
Spisak PDB ID kodova

1N0W, 3EU7

Identifikatori
AliasiBRCA2
Vanjski ID-jeviOMIM: 600185 MGI: 109337 HomoloGene: 41 GeneCards: BRCA2
Lokacija gena (čovjek)
Hromosom 13 (čovjek)
Hrom.Hromosom 13 (čovjek)[1]
Hromosom 13 (čovjek)
Genomska lokacija za BRCA2
Genomska lokacija za BRCA2
Bend13q13.1Početak32,315,086 bp[1]
Kraj32,400,268 bp[1]
Lokacija gena (miš)
Hromosom 5 (miš)
Hrom.Hromosom 5 (miš)[2]
Hromosom 5 (miš)
Genomska lokacija za BRCA2
Genomska lokacija za BRCA2
Bend5 G3|5 89.52 cMPočetak150,446,095 bp[2]
Kraj150,493,794 bp[2]
Obrazac RNK ekspresije
Više referentnih podataka o ekspresiji
Ontologija gena
Molekularna funkcija vezivanje sa DNK
H4 histone acetyltransferase activity
H3 histone acetyltransferase activity
protease binding
histone acetyltransferase activity
GO:0001948, GO:0016582 vezivanje za proteine
gamma-tubulin binding
single-stranded DNA binding
protein C-terminus binding
vezivanje identičnih proteina
Ćelijska komponenta centrosom
BRCA2-MAGE-D1 complex
secretory granule
nukleoplazma
centar organizacije mikrotubula
jedro
citoskelet
lateralni element
citoplazma
citosol
GO:0009327 makromolekulani kompleks
Biološki proces chordate embryonic development
Popravak ekscizijom nukleotida
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
DNA recombination
regulation of cytokinesis
replication fork protection
centrosome duplication
male meiosis I
negative regulation of mammary gland epithelial cell proliferation
positive regulation of mitotic cell cycle
GO:0051312, GO:0007083 chromosome organization
female gonad development
inner cell mass cell proliferation
GO:0060469, GO:0009371 positive regulation of transcription, DNA-templated
telomere maintenance via recombination
brain development
oocyte maturation
histone H3 acetylation
Spermatogeneza
intrinsic apoptotic signaling pathway in response to DNA damage
establishment of protein localization to telomere
histone H4 acetylation
cellular response to DNA damage stimulus
ćelijski ciklus
Ćelijska proliferacija
response to gamma radiation
response to UV-C
response to X-ray
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator
GO:1903211 mitotic recombination-dependent replication fork processing
double-strand break repair via homologous recombination
GO:0100026 Popravka DNK
double-strand break repair
mitotic cytokinesis
Hematopoeza
response to nutrient
meiotic DNA repair synthesis involved in reciprocal meiotic recombination
mammary gland development
homologous chromosome orientation involved in meiotic metaphase I plate congression
response to estradiol
multicellular organism growth
DNA synthesis involved in double-strand break repair via homologous recombination
Kontrolna tačka mejotske rekombinacije
Izvori:Amigo / QuickGO
Ortolozi
VrsteČovjekMiš
Entrez
Ensembl
UniProt
RefSeq (mRNK)

NM_000059

NM_001081001
NM_009765

RefSeq (bjelančevina)

NP_000050

NP_001074470
NP_033895

Lokacija (UCSC)Chr 13: 32.32 – 32.4 MbChr 5: 150.45 – 150.49 Mb
PubMed pretraga[3][4]
Wikipodaci
Pogledaj/uredi – čovjekPogledaj/uredi – miš
Ponavljanje BRCA2
Kristalna struktura ponavlajajućeg kompleksa rad51-brca2
Identifikatori
SimbolBRCA2
BRCA-2 heliks
Struktura kompleksa brca2-dss1
Identifikatori
SimbolBRCA-2_helical
BRCA2, oligonukleotid/oligosaharid-vezujući domen 1
Struktura kompleksa brca2-dss1
Identifikatori
SimbolBRCA-2_OB1
BRCA2, oligonuKleotid/oligosaharid-vezujući domen 3
Struktura kompleksa brca2-dss1
Identifikatori
SimbolBRCA-2_OB3
Domrn Tower
Struktura kompleksa brca2-dss1
Identifikatori
SimbolTower

BRCA2[5]) je ljudski gen, odnosno njegov proteinski proizvod. Službeni simbol (BRCA2, kurziv za gen, neitalik za protein) i službeni naziv (izvorno rak dojke 2, sada BRCA2 vezana popravka DNK) su podržane u HUGO Odboru za gensku nomenklaturu. Jedan alternativni simbol, FANCD1, prepoznaje njegovu povezanost sa kompleksom FANC proteina. Ortolozi, oblikovani kao Brca2 i Brca2, česti su i kod drugih kičmenjačnih vrsta.[6][7] BRCA2 ie tumor-supresorski gen[8][9] (posebno, domćinski gen), koji se nalazi u svih ljudi; njegov protein, koji se sinonimno naziva i protein osjetljiv na rak dojke tipa 2, odgovoran je za popravak DNK.[10]

BRCA2 i BRCA1 se normalno eksprimiraju u ćelijamama dojke i drugog tkiva, gdje pomažu u obnavljanju oštećene DNK ili uništavanju ćelija ako se DNK ne može popraviti. Uključeni su u popravak oštećenja hromosoma, s važnom ulogom u popravakama greašaka u formiranju dvostrukih lanaca.[11][12] Ako je sam BRCA1 ili BRCA2 oštećen BRCA mutacijama, oštećena DNK se ne popravlja ispravno, a to povećava rizik od raka dojke.[13][14] BRCA1 i BRCA2 opisani su kao "geni osjetljivosti na rak dojke" i "proteini osjetljivosti na rak dojke". Prevladavajući alel ima normalnu tumor-supresivnu funkciju, dok visoko penetrirane mutacije u tim genima uzrokuju gubitak tumorske supresivne funkcije, što je u korelaciji s povećanim rizikom od raka dojke.[15]

Gen BRCA2 nalazi se na dugom (q) kraku hromosoma 13, na poziciji 12.3 (13q12.3).[16] Ljudski referentni gen BRCA2 sadrži 27 egzona, a and the cDNK ima 10.254 baznih parova[17] za kodiranje proteina od 3.418 aminokiselina.[18][19] Karcinom dojke (uključujući i muški): Međuodnosi fenotipgenotip[20][21][22]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000139618 - Ensembl, maj 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000041147 - Ensembl, maj 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Hamel PJ (29. 5. 2007). "BRCA1 and BRCA2: No Longer the Only Troublesome Genes Out There". HealthCentral. Pristupljeno 2. 7. 2010.
  6. ^ "OrthoMaM phylogenetic marker: BRCA2 coding sequence". Arhivirano s originala, 3. 3. 2016. Pristupljeno 19. 2. 2010.
  7. ^ "BRCA2 gene tree". Ensembl.
  8. ^ Duncan JA, Reeves JR, Cooke TG (oktobar 1998). "BRCA1 and BRCA2 proteins: roles in health and disease". Molecular Pathology. 51 (5): 237–47. doi:10.1136/mp.51.5.237. PMC 395646. PMID 10193517.
  9. ^ Yoshida K, Miki Y (novembar 2004). "Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage". Cancer Science. 95 (11): 866–71. doi:10.1111/j.1349-7006.2004.tb02195.x. PMID 15546503. S2CID 24297965.
  10. ^ Check W (1. 9. 2006). "BRCA: What we know now". College of American Pathologists. Pristupljeno 23. 8. 2010.
  11. ^ Friedenson B (august 2007). "The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers". BMC Cancer. 7 (1): 152–162. doi:10.1186/1471-2407-7-152. PMC 1959234. PMID 17683622.
  12. ^ Friedenson B (8. 6. 2008). "Breast cancer genes protect against some leukemias and lymphomas" (video). SciVee.
  13. ^ "Breast and Ovarian Cancer Genetic Screening". Palo Alto Medical Foundation. Arhivirano s originala, 4. 10. 2008. Pristupljeno 11. 10. 2008.
  14. ^ Friedenson B (2007). "The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers". BMC Cancer. 7 (1): 152. doi:10.1186/1471-2407-7-152. PMC 1959234. PMID 17683622.
  15. ^ O'Donovan PJ, Livingston DM (april 2010). "BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair". Carcinogenesis. 31 (6): 961–7. doi:10.1093/carcin/bgq069. PMID 20400477.
  16. ^ Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D (septembar 1994). "Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13". Science. 265 (5181): 2088–90. Bibcode:1994Sci...265.2088W. doi:10.1126/science.8091231. PMID 8091231.
  17. ^ "BRCA2 breast cancer 2, early onset [Homo sapiens]". EntrezGene. National Center for Biotechnology Information, U.S. National Library of Medicine.
  18. ^ "Breast cancer type 2 susceptibility protein - Homo sapiens (Human)". P51587. UniProt.
  19. ^ Williams-Jones B (2002). Genetic testing for sale: Implications of commercial brca testing in Canada (Ph.D.). The University of British Columbia.
  20. ^ OMIM Entry Search - brca3
  21. ^ OMIM Entry - # 114480 - BREAST CANCER
  22. ^ https://omim.org/search?index=entry&sort=score+desc%2C+prefix_sort+desc&start=1&limit=10&search=brca3

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne